Clinical Trials Validating Kurve’s Technology Platform
As we advance through each clinical trial phase, we want to offer transparency and insight into our efforts. We have successfully met our endpoints in Phase IIb in 3 separate clinical trials and are currently Phase III ready.
This is where you can find the latest list of clinical trials that Kurve has participated in, for which our next-generation technology was the device of choice.
clinical trials
Rigorously Tested
We hold to the highest levels of transparency and integrity when it comes to sharing the results of our ongoing clinical trial phase. So far, we’ve met our endpoints in 3 separate clinical trials (Phase 2b) and are cleared to begin Phase 3. Here’s the latest trials we’ve participated in where our next-generation technology was the device of choice:
| Field of Study | Conducted by |
| Alzheimer’s Disease | Johns Hopkins |
| Alzheimer’s Disease (Phase I, II and IIB) | Wake Forest |
| Alzheimer’s Disease | Shankle Neurology Clinic |
| Parkinson’s Disease | Shankle Neurology Clinic |
| Parkinson’s Disease | University of Massachusetts |
| Multi-System Atrophy | University of Massachusetts |
| Cognition in Diabetics | Harvard Medical School |
| Cognition in multiple sclerosis (MS) | Johns Hopkins |
| Traumatic Brain Injury | Department of Defense |
| PTSD | Department of Defense |
| PTSD | Mount Sinai School of Medicine |
| Neuropathic Pain | Johns Hopkins |
| Mood and Anxiety Disorders | Karolinska University (Sweden) |
| Life Extension | Leiden University (Netherlands) |
| Autism | Pastorus |